Sign inJoin waitlistJoin the waitlist

Jennifer Crombie

Assistant Professor of Medicine, Harvard Medical School · Mass General Brigham

Credentials: · · · · ·

History

Mass General Brigham
Present

Hematology and Medical Oncology
Dana-Farber Cancer Institute
2015–2018
Internal Medicine
Brigham and Women's Hospital
2012–2015
University of Massachusetts Medical School
2008–2012
Dartmouth College
2004–2008

Research

Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort…
The Lancet Haematology · 2022 · 243 citations
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
Blood · 2019 · 201 citations
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Blood · 2019 · 152 citations

Philippe Armand
36 papers
Ann LaCasce
26 papers
Caron Jacobsen
26 papers
David Fisher
23 papers
Matthew Davids
21 papers
Reid Merryman
21 papers · 3 as a fellow
Austin Kim
19 papers
Jennifer Brown
18 papers
Eric Jacobsen
15 papers
AH
Alex Herrera
13 papers
Oreofe Odejide
12 papers
Erin Parry
10 papers

Clinical trials

Pembro Plus CAR T-cell Therapy in R/R in PMBCL
Principal investigator · Recruiting · Phase 2
Jennifer Crombie, MD
2023–2031
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
Principal investigator · Recruiting · Phase 2
Jennifer Crombie, MD
2023–2029
Copanlisib Plus Venetoclax in R/R DLBCL
Principal investigator · Active not recruiting · Phase 1, Phase 2
Dana-Farber Cancer Institute
2021–2026
Safe Accelerated Venetoclax Escalation in CLL
Principal investigator · Active not recruiting · Phase 1
Dana-Farber Cancer Institute
2021–2030